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Objectives The purpose of this study is to understand whether naturally occurring genetic variation in the promoter of chro-
mogranin B (CHGB), a major constituent of catecholamine storage vesicles, is functional and confers risk for
cardiovascular disease.
Background CHGB plays a necessary (catalytic) role in catecholamine storage vesicle biogenesis. Previously, we found that
genetic variation at CHGB influenced autonomic function, with association maximal toward the 5= region.
Methods Here we explored transcriptional mechanisms of such effects, characterizing 2 common variants in the proximal pro-
moter, A-296C and A-261T, using transfection/cotransfection, electrophoretic mobility shift assay (EMSA), and chro-
matin immunoprecipitation (ChIP). We then tested the effects of promoter variation on cardiovascular traits.
Results The A-296C disrupted a c-FOS motif, exhibiting differential mobility shifting to chromaffin cell nuclear proteins
during EMSA, binding of endogenous c-FOS on ChIP, and differential response to exogenous c-FOS. The A-261T
disrupted motifs for SRY and YY1, with similar consequences for EMSA, endogenous factor binding, and re-
sponses to exogenous factors. The 2-SNP CHGB promoter haplotypes had a profound (p  3.16E-20) effect on
blood pressure (BP) in the European ancestry population, with a rank order of CTAACAAT on both systolic
blood pressure (SBP) and diastolic blood pressure (DBP), accounting for 2.3% to 3.4% of SBP/DBP variance;
the haplotype effects on BP in vivo paralleled those on promoter activity in cella. Site-by-site interactions at
A-296C and A-261T yielded highly nonadditive effects on SBP/DBP. The CHGB haplotype effects on BP were
also noted in an independent (African ancestry) sample. In normotensive twins, parallel effects were noted for a
pre-hypertensive phenotype, BP response to environmental stress.
Conclusions The common CHGB promoter variants A-296C and A-261T, and their consequent haplotypes, alter binding of
specific transcription factors to influence gene expression in cella as well as BP in vivo. Such variation contrib-
utes substantially to risk for human hypertension. Involvement of the sex-specific factor SRY suggests a novel
mechanism for development of sexual dimorphism in BP. (J Am Coll Cardiol 2010;55:1463–75) © 2010 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.11.064e
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CHGB Transcription and Hypertension April 6, 2010:1463–75mones, transmitters, and neuropep-
tides throughout the endocrine and
nervous system (2). Chromogranin
B (CHGB), first described in the
1980s (3–5), is a major catechol-
amine storage vesicle core protein
and seems to play a necessary role in
the biogenesis of catecholamine se-
cretory vesicles (6).
CHGB is differentially ex-
pressed in neuroendocrine dis-
eases, and its measurement may
serve in the diagnosis and staging
of such conditions (7–15). Interac-
tion of CHGB with signaling
molecules such as the inositol-
1,4,5-trisphosphate-activated cal-
cium channel (16) may influence
cytosolic calcium and ultimately
risk for such disease states as
Alzheimer’s disease, epilepsy, or
schizophrenia (17). In addition,
polymorphisms in the CHGB gene
may be associated with schizophre-
nia in Chinese and Japanese popu-
lations (18,19).
Expression of CHGB may
mark the action of still poorly
characterized trans-quantitative
trait locus (QTL) influencing
exocytotic sympathoadrenal ac-
tivity (20,21). CHGB is overex-
ressed in rodent models of genetic (22,23) as well as
cquired (24) hypertension, thus suggesting augmented
ympathoadrenal activity in the pathogenesis of these syn-
romes. Therefore, CHGB might give rise to early, patho-
enic “intermediate phenotypes” (25) for exploration of
ympathoadrenal activity in human essential hypertension.
Previously, we described genetic variation at the CHGB
ocus, and concluded that sex and CHGB interact to
nfluence blood pressure (BP) (26). Since the association of
HGB genetic variation to BP was maximal toward the 5=
nd of the gene, and such variation predicted quantitative
hanges in CHGB expression, we turned to potential
ranscriptional mechanisms. Here, we characterize the
roximal promoter region of CHGB, discovering 2 com-
on polymorphisms that disrupt transcription factor
inding, giving rise to systemic hypertension. One of
hese sites recognizes the sex-specific factor, sex-
etermining region Y (SRY), providing insight into the
exual dimorphism of BP.
ethods
ubjects and clinical characterization. Subjects were vol-
Abbreviations
and Acronyms
ANOVA  analysis of
variance
BMI  body mass index
BP  blood pressure
CHGB  chromogranin B
ChIP  chromatin
immunoprecipitation
DBP  diastolic blood
pressure
DNA  dioxyribonucleic
acid
EMSA  electrophoretic
mobility shift assay
HWE  Hardy-Weinberg
equilibrium
LD  linkage disequilibrium
MAF  minor allele
frequency
OR  odds ratio
QTL  quantitative trait
locus
SBP  systolic blood
pressure
SNP  single nucleotide
polymorphism
SRY  sex-determining
region Y
YY1  Yin-Yang 1nteers, and each gave informed, written consent to proto- pols approved by local institutional review boards. Recruit-
ent procedures, definitions, and confirmation of subject
iagnoses are according to previous reports.
ystematic polymorphism discovery across the CHGB locus.
s previously described (26), we resequenced each of
HGB’s 5 exons, exon/intron borders, untranslated region,
nd proximal promoter in n  160 subjects (2n  320
hromosomes) of 4 self-identified biogeographic ancestries:
hite/European (n  56), black/sub-Saharan African (n 
6), Hispanic/Mexican American (n  24), and east Asian
n  24). We used an ABI-3100 capillary system (Applied
iosystems, Foster City, California) to accomplish dideoxy
equencing.
rimary care population with extremes of high and low
P. EUROPEAN ANCESTRY. As previously described (26),
e ascertained 951 European-ancestry subjects, approxi-
ately half male and half female, from the highest and
owest fifth diastolic blood pressure (DBP) percentiles of a
arge primary care population in the Kaiser-Permanente
edical Group of Southern California (27). The DBP
riterion was chosen because of the heritability of DBP (28).
he statistical power of association between biallelic de-
xyribonucleic acid (DNA) markers and human quantitative
rait loci can be substantially augmented by the sample
ubjects from opposite (upper and lower) ends of the trait
istribution (29–31); and analyses of the quantitative trait in
xtreme subjects (as opposed to dichotomization of the
rait) further enhances power (32). This population sample
fforded us 90% power (29,30) to detect genotype asso-
iation with a trait when the genotype contributes as little as
.5% to the total variation in males (even at p  108); the
ower is even higher in females (31). Evaluation included
hysical examination, blood chemistries, hemogram, and
xtensive medical history questionnaire. Of the hypertensive
roup, 40.6% were receiving antihypertensive medications,
hereas none in the normotensive group was receiving such
rugs. The subjects are described in Online Table 1.
verall, 1.98% of subjects were excluded because of elevated
erum creatinine (1.5 mg/dl).
lack population with blood pressure extremes. SUB-SAHARAN
FRICAN ANCESTRY. Three hundred fifty-seven adult Nige-
ians (approximately one-half male, one-half female) se-
ected from the highest (n  191) and lowest (n  190)
5th percentiles of population BP were included as a
eplication sample for CHGB promoter variant effects on
P. This population has been described (33).
win pairs. EUROPEAN ANCESTRY. In studies of the influ-
nce of CHGB polymorphism on the pressor response to
nvironmental stress in vivo, 156 twin pairs and 80 siblings
312 individual subjects) were evaluated. The response of
P to cold stress (by immersion of 1 hand in ice water for
min) was evaluated as previously described (34); responses
herein DBP increased after cold stress were analyzed.
ygosity (69% monozygotic and 31% dizygotic pairs) was
onfirmed by extensive microsatellite and single nucleotide
olymorphism (SNP) genotyping, as described (35). Twins
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April 6, 2010:1463–75 CHGB Transcription and Hypertensionanged in age from 15 to 84 years; 10% were hypertensive.
wins in these allelic/haplotype association studies were self-
dentified as of European (white) ancestry, to guard against
otential artifactual effects of population stratification.
tatistical analyses. Haplotype blocks were visualized in
aploview (36), while haplotype assignments in individual
ubjects were performed by the HAP algorithm (37) in
ndividual subjects with both A-296C and A-261T geno-
ypes. Chi-square tests were performed to test for deviations
rom the Hardy-Weinberg equilibrium (HWE). When
esting for associations of haplotypes with continuous/
uantitative BP traits, sex, age, and body mass index (BMI)
ere included as covariates in the univariate tests of the
eneral linear model using SPSS version 11.5 software
SPPS Inc., Chicago, Illinois). Both the final measured BP
nd that BP adjusted for the effects of antihypertensive
edication (38) were analyzed. Each factor was then as-
essed for significance using standard analysis of variance
ANOVA) F-tests (39). Haplotype analyses were both
diploid) individual based as well as chromosome based;
ere, each haplotype allele (as opposed to a haplotype allele
air) was considered and analyzed separately, using the
utcomes and characteristics of the subject carrying that
llele (40). Associations between BP status and allele, geno-
ype or haplotype were analyzed in n  2 tables by either
NOVA or by SHEsis (41). Twin analyses were conducted in
ways: twin trait heritability (h2) was estimated in SOLAR
Southwest Foundation for Biomedical Research, San Anto-
io, Texas) (42); twin descriptive and inferential statistics were
omputed by using generalized estimating equations in SAS
oftware (SAS Institute, Cary, North Carolina), to account for
ntrapair correlations (35). A p value of 0.05 was considered
ignificant.
ENOMICS. Genomic DNA was prepared from leukocytes
n ethylenediaminetetra-acetic acid–anticoagulated blood,
sing PureGene extraction columns (Gentra Systems, Min-
eapolis, Minnesota).
OLECULAR BIOLOGY. Transfected CHGB promoter hap-
otype/luciferase reporter activity, genotyping of CHGB
ariants, electrophoretic gel mobility shift assays (EMSA),
nd chromatin immunoprecipitation (ChIP) were per-
ormed (for details, see the Online Appendix).
esults
atterns of linkage disequilibrium across CHGB locus.
o visualize association patterns, 16 SNPs (each in HWE)
ere scored and plotted by Haploview as pairwise linkage
isequilibrium (LD) parameter r2 across the 14 kbp locus.
he proximal promoter (including common variants
-296C and A-261T) was maintained within a single block
n both white subjects and black subjects. The allele and
enotype frequencies differed between white and black
opulations (Online Table 2). Although pairwise r2 values
ere generally higher in white subjects than in black tubjects, just 2 LD blocks spanned the locus in each group
Fig. 1A). The original resequencing strategy and SNP
iscovery have been described (26).
omains and motifs in the CHGB promoter. Figure 1B
iagrams known motifs in the CHGB promoter, and super-
mposes common variants. Functional domains in the core/
roximal promoter (such as the TATA box, cyclic-
denosine monophosphate response element, and G/C-rich
egions) were invariant in 180 people (360 chromo-
omes) subjected to systematic polymorphism discovery by
esequencing.
Two very common SNPs (minor allele frequency [MAF]
30%) occur in the proximal promoter: A-296C and A-261T,
hose allele, diploid genotype, and haplotype frequencies
iffered by ethnicity (Online Table 2). The A-296C variant lies
n a c-FOS transcriptional control motif (-298/-291), whereas
-261T lies in recognition motifs for both Yin-Yang 1 (YY1)
-264/-259) and SRY (-265/-260).
HGB promoter haplotype/reporter activity assays. To
robe the functional significance of the 2 common promoter
ariants for transcriptional efficiency, we inserted each of the
haplotypes of the 2 promoter SNPs (A-296C and
-261A) into the luciferase reporter plasmid pGL3-
asic (Online Fig. 1). After transfection into rat chro-
affin (PC12) cells, these 4 haplotypes yielded substan-
ially different luciferase reporter activity (Table 1).
ite-specific effect analysis of reporter activity showed
hat both A-296 and A-261 have context-dependent
ctions. The strengths of combinations of A-296C and
-261T were ATCTAACT (p  8.46E-07) (Table
). By 2-way ANOVA, overall F  107.2, p  8.46E-07;
-296C, p  2.09E-05; A-261T, p  0.064; and 296-by-
61 interaction, p  3.07E-07.
ecretory stimulation. We evaluated responses of CHGB
romoter haplotypes to agents simulating natural secretory
timuli (Fig. 1C). Pituitary adenylate cyclase-activating
eptide increased promoter activity by 4.1- to 7.7-fold
p  4.86E-14), while nicotine increased activity by 0.6-
old to 1.5-fold (p  1.34E-8). There were differences
mong the 4 haplotypes in response to pituitary adenylate
yclase-activating peptide (p  1.9E-5), although nicotine
esponses were similar (p  0.31).
HGB promoter variant A-296C. The A-296C variant
ies in an evolutionarily conserved region among humans,
onhuman primates, and other mammals (Online Fig. 2).
uring EMSA, a labeled oligonucleotide representing the
allele was shifted by PC12 nuclear proteins; specificity
as suggested by displacement with the same (C) allele
hen unlabeled (Online Fig. 3).
A-296C occurred in a potential recognition site for
ranscription factor c-FOS, with a 7/8 base consensus match
or the A allele (43), declining to 6/8 for the C allele (Fig.
A). When interrogated by ChIP, endogenous c-FOS
inding to the motif was detected in all 4 haplotypes,
lthough unexpectedly more intense for the A-296C than
he A-296 allele (Fig. 2A).
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CHGB Transcription and Hypertension April 6, 2010:1463–75When a plasmid expressing c-FOS was cotransfected into
C12 cells with CHGB promoter/reporters, all 4 CHGB
aplotypes responded (p  2.36E-9), although unequally
p  7.23E-5). On a haplotypic background of the A-261
llele, c-FOS stimulated A-296 and A-296C similarly,
lthough on a background of the -261T allele, the transcrip-
White
2n=112 
LD blocks derived by solid spine method in Haploview
Value shown: r2×100
r2 color scheme:  r2=0, white; 0<r2<1, shades of grey; r2=1: bla
Common SNPs: MAF>10%
C-1239T
A-26
A-296C
c-FOS
[-298/-291]
TG(A/C)GGCAC
SR
[-265/-
TACC(A
Variants: Minor allele frequency >20%
(Parentheses): SNP variant, e.g. (C/T)
[Brackets]: Predicted motif
G/C-rich d
232, -221/-2
72, -70/-63,
A
B
Figure 1 Human CHGB Promoter Genetic Variation
(A) Human chromogranin B (CHGB) common single nucleotide polymorphism (SNP) lin
in Haploview. Resequencing was accomplished across the 5 exons, exon/intron borde
European ancestry, and for n  56 of sub-Saharan African ancestry. (B) Human C
the messenger ribonucleic acid (mRNA) cap (transcriptional initiation) site. The CH
phosphate (cAMP) response element at -119/-112 bp. There are 2 common varian
tal promoter (C-1239T). Continued on the next page.ional response of A-296 was far greater than that of D-296C (Fig. 2B). Thus, the A-296C response to exoge-
ous c-FOS seemed to be context dependent.
HGB promoter variant A-261T. A-261T variant also
ccurs in an evolutionarily conserved region (Online Fig. 4).
uring EMSA, the T allele was more effectively shifted by
C12 nuclear proteins than the A allele (Online Fig. 5).
Black
2n=112
TATA box 
[-44/-38]
TTTAAAA
Transcriptional
start (cap) site
Exon 1
112 bp 5’-UTR
T+55C
MP response element 
[-119/-112]
TGACGTCA
YY1
[-264/-259]
ACC(A/T)TC 
5’-UTR
ATG
|
s: -319/-314, -276/-271, -237/-
4/-198, -156/-151, -100/-89, -80/-
, -35/-28, -26/-13, -9/-2
GB core promoter
[-319/-1]
isequilibrium (LD) blocks. The LD blocks were derived by the solid spline algorithm
Rs, and proximal promoter. Results are shown for n  56 subjects of white/
romoter common variants and domains: positions are numbered with respect to
moter has a functional TATA box at -44/-38 bp, and a cyclic-adenosine mono-
roximal promoter (A-296C and A-261T), with 1 common variant in the more dis-ck
1T
cA
 
Y
260]
/T)T 
omain
14, -20
 -61/-50
CH
kage d
rs, UT
HGB p
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April 6, 2010:1463–75 CHGB Transcription and Hypertensionas shifted by PC12 nuclear proteins, while the T allele was
hifted to a lesser degree; specificity was suggested, espe-
ially for the A allele, by displacement with the same allele
hen unlabeled (Online Fig. 5).
A-261T occurred in potential recognition motifs for the
ranscription factors SRY and YY1: the A allele displayed a
uperior match to both SRY (5 of 6 bases) (44,45) and YY1
6 of 6 bases) (43) motifs, as compared with the T allele
Fig. 3B). Involvement of endogenous SRY and YY1 was
robed by ChIP (Fig. 3A): for both SRY and YY1, the A
llele was more effectively bound than the T allele, on either
-296C haplotypic background.
0
5
10
15
20
25
A-296/A-261 A-296/-261T -296C/A-261 -296C/-261T
No treatment
Nicotine 1mM
PACAP 200 nM
2-way ANOVA:
Nicotine: F=110.78, p=1.34E-08
Nicotine*Hap: F=1.29, p=0.31
PACAP: F=587.4, p=4.86E-14
PACAP*Hap: F=18.47, p=1.9E-5
Haplotypes
L
u
ci
fe
ra
se
 r
ep
o
rt
er
 a
ct
iv
it
y,
F
ir
ef
ly
/t
o
ta
l p
ro
te
in
C
Figure 1 Continued
(C) Luciferase reporter activity of CHGB promoter 2-SNP haplotype constructs:
shown are basal activity (open bars) as well as the transcriptional responses to
classical chromaffin cell secretory stimuli, nicotine (solid bars) (acting at nicotinic
cholinergic receptors) and pituitary adenylate cyclase-activating peptide (PACAP)
(striped bars). Analysis of variance (ANOVA) was computed on unadjusted data for
each state, rather than fold-change. MAF  minor allele frequency.
CHGB Promoter Variants A-296C and A-261T:ontext-Dependent Allelic Effects on LuciferaseTable 1 CHGB Promoter Variants 96C anContext-Dependent Allelic Effects o
Variant Context Allele
Lu
Mean
A-296C -261T A-296 4.144
-296C 1.104
A-261 A-296 1.942
296C 2.767
A-261T A-296 A-261 1.942
-261T 4.144
-296C A-261 2.767
-261T 1.104The relative activities of haplotypic combinations of A-296C and A-261T are
A-296C, p  2.09E-05; A-261T, p  0.064; 296-by-261 interaction, p  3.07When a plasmid expressing SRY was cotransfected into
C12 cells with CHGB promoter/reporters, all 4 haplotypes
howed decreased reporter activity (p  1.15E-10) (Fig.
B), although the degree of inhibition depended on
-296C background (p  4.29E-8).
When cotransfected with a YY1 expression plasmid,
HGB promoter reporter activity increased for each haplo-
ype (p  7.6E-10), and the effect was more prominent for
he A-261 allele than for the A-261T allele, regardless of
-296C context (p  1.64E-4) (Fig. 3B).
HGB promoter common variants A-296C and A-261T.
MPLICATIONS FOR HYPERTENSION IN THE POPULATION.
ere we studied BP trait-extreme subjects of European ances-
ry, to enhance statistical power (29,30). Chromosome-based
aplotype analysis on subjects dichotomized into 2 groups
higher BP vs. lower BP) indicated that subjects with the less
ommon AT or CA haplotypes had a strong tendency to be
ypertensive (odds ratio [OR]: 4.898 for AT haplotype, p 
.19E-11; OR: 3.84 for CA haplotype, p  3.64E-10).
ubjects with the more common haplotype CT had a strong
endency to be normotensive (OR: 0.637, 95% confidence
nterval: 0.524 to 0.773, p  4.64E-6). The most common
aplotype AA had no effect on blood pressure status. The
verall effect of CHGB haplotypes on BP status was substantial
Fig. 4A, Table 2), whether analyzed by chromosome/haplotype
global chi-square 93.9, p 3.16E-20), or by diploid haplotype
airs (global chi-square  75.0, p  4.92E-13).
Single SNP-based allele tests showed far less power to
etect BP associations (Table 2): A-296C (although not
-261T) had an effect on BP status (p  0.038), with the
-296 allele tending toward hypertension. Of note, when
ubjects were stratified by sex, A-261T displayed significant
ffects on systolic blood pressure (SBP)/DBP in males (p 
.001/p  0.011), although not in females.
We also pursued association of the quantitative traits
SBP and DBP in mm Hg) with CHGB haplotypes (Fig.
B), and here we found substantial predictions for both SBP
nd DBP. With increasing copy number (0, 1, 2) of haplotype
T, SBP increased by29 mm Hg (p 0.0002), while DBP
ncreased by 21 mm Hg (p  1.59E-5), each in additive
rter Activity61T:
iferase Reporter Activity
e
Change %
(Major¡Minor)
2-Tailed t Test
(p Value)SEM
0.173 73.36 0.0006
0.087
0.103 42.47 0.007
0.121
0.103 113.4 0.0011
0.173
0.121 60.10 0.0006
0.087Repod A-2
n Luc
ciferas: ATCAAACT. 2-way ANOVA: overall F  107.2, p  8.46E-07;
E-07.
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CHGB Transcription and Hypertension April 6, 2010:1463–75ashion. With increasing copy number of haplotype CA, SBP
ncreased by13 mm Hg (p 0.005) while DBP increased
y 12 mm Hg (p  8.49E-6). With increasing copy
umber of haplotype CT, however, SBP decreased by 11
m Hg (p  0.0045), with a parallel decrease in DBP by
c-FOS (rev comp)  TGASTCA
Human A-296:      TGAGGCAC
Human -296C:      TGCGGCAC
Chimp:            TGAGGCAC
Rhesus:           TGAGGCAA
Orangutan:        TGAGGCAC
Conserved:        ** * **
Human A-296C v
tupnI c-FO
AT      AA        CT     CA
La
dd
er
AT      AA    
CHGB promoter com
ChIP (Chromatin Im
0
200
400
600
800
1000
1200
A-296 -296C
2-way ANOVA:
Overall: F=38.236, p=1.6
Genotype: F=49.404, p=
c-FOS: F=84.948, p=2.36
Genotype*c-FOS: F=11.4
CHGB: 1 µg 
pcDNA3.1 (vector) or c-F
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CHGB h
A-261 context
A
B
Figure 2 Functional Characterization of CHGB Promoter Comm
(A) Endogenous c-FOS: motif and chromatin immunoprecipitation (ChIP). A-296 cre
by ChIP on all 4 2-single nucleotide polymorphism (SNP) haplotypes, although mor
the reverse complement (i.e., minus) strand. The c-FOS core motif, TGASTCAC, is
tional Union of Pure and Applied Chemistry) symbols can be found at http://www.
on transcriptional activity of chromogranin B (CHGB) promoter haplotypes in PC12
although the magnitude is haplotype-dependent, especially in the -261T context. O7 mm Hg (p 0.011). When we adjusted BP values for the tffects of antihypertensive medications in treated hyperten-
ive patients (38), the haplotype effects on SBP/DBP persisted
r increased: AT, p  4.1E-5/p  6.83E-6; CA, p  0.008/
 2.04E-5; and CT, p 0.002/p 0.008. Haplotypes AA
nd AT displayed more prominent effects on BP in females
Match
7/8
6/8
7/8
6/8
7/8
nt
Bold: Sequence identity 
with c-FOS motif.
S: G/C (IUPAC code)
)lortnoc( GgI
-180 bp
-296/-261   CA AT      AA        CT     CA
 variant A-296C:
oPrecipitation)
A-296 -296C
pcDNA3.1 (vector)
c-FOS10
7.23E-5
00 ng
ypes
-261T context
A-296C
allele
riant A-296C
7/8 bp match with c-FOS. Experimentally, endogenous c-FOS can be captured
se at -296C than at A-296. The sequence match for the c-FOS binding site is on
in the JASPAR (43) transcription factor binding database. The IUPAC (Interna-
rmatics.org/sms/iupac.html. (B) Exogenous c-FOS: effect of cotransfected c-FOS
affin cells. c-FOS (solid bars) consistently increases CHGB promoter expression,
ars indicate pcDNA3.1 (vector). ANOVA  analysis of variance.C   
   
   
   
   
   
aria
S
    CT  
mon
mun
6E-11
2.02E-
E-09
98, p=
OS: 1
aplot
on Va
ates a
e inten
found
bioinfo
chrom
pen bhan in males, whereas CT had a greater effect in males.
n
S
m
a
a
t

a
p
(
t
1469JACC Vol. 55, No. 14, 2010 Zhang et al.
April 6, 2010:1463–75 CHGB Transcription and HypertensionPromoter polymorphisms A-296C/A-261T interacted
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Figure 4 CHGB Promoter Haplotypes and BP in a Population Sample With Extreme Trait Values
The haplotypes are constructed across promoter polymorphisms A-296C/A-261T. (A) Prediction of blood pressure (BP) status by chromogranin B (CHGB) promoter haplotypes in
white (European ancestry) BP extremes. Haplotypes (or haplotype pairs) are ordered by rank of association with elevated BP: haplotype pair (diploid haplotype) effects (left), and
haplotype (chromosome) effects (right). Open bars  hypertensive (HT); solid bars  normotensive (NT). The 2 most common haplotypes (AA and CT) are more frequent in sub-
jects with lower BP, while the 2 less common haplotypes (CA and AT) are more frequent in subjects with higher BP. (B) CHGB promoter haplotypes in white BP extreme sub-
jects: effect of copy number. Three haplotypes demonstrated copy number (0, 1, 2) dependent effects on both diastolic blood pressure (DBP) and systolic blood pressure (SBP).
Haplotypes AT and CA increased blood pressure, whereas CT decreased blood pressure. Age, sex, and body mass index (BMI) had significant effects on SBP and DBP; thus,
analyses included age, sex, and BMI as covariates. ANOVA  analysis of variance. (C) CHGB promoter common polymorphisms A-296C/A-261T: effect of single nucleotide poly-
morphism (SNP)-by-SNP interaction on BP in white trait extremes. For A-296C polymorphism, on the background of A/A (major allele) homozygosity, both SBP and DBP were ele-
vated progressively by A/A (open bars) A/T (striped bars) T/T (solid bars) genotypes at A-261T (accounting for 27 mm Hg SBP and 22 mm Hg DBP); on a background
of C/C (minor allele) homozygosity, both SBP and DBP declined progressively as a function of A/AA/TT/T genotypes at A-261T (accounting for 22 mm Hg SBP and 18
mm Hg DBP). (Left) Interaction effect on SBP, 2-way ANOVA: overall: F  33.67, p  9.34E-61; interaction: F  8.4, p  1.15E-6. (Right) Interaction effect on DBP, 2-way
ANOVA: overall: F  36.27, p  6.16E-65; interaction: F  13.49, p  1.07E-10. Continued on the next page.
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.18E-12). On ANOVA, CHGB promoter genetic varia-
ion accounted for 2.3% of SBP variance and 3.4% of
BP variance in this primary care population.
arallel effects of human CHGB promoter haplotypes in
ivo and in cella. Of note, the 4 promoter haplotypes
isplay the same rank order for effects on BP in vivo and
uciferase reporter activity in chromaffin cells in cella (Fig.
D, right).
xtension to a second population. SUB-SAHARAN AFRICAN
YPERTENSION. An association between CHGB promoter
Figure 4 Continued
(D) CHGB promoter common polymorphisms A-296C/A-261T: parallel effects on B
of BP in the white trait extreme sample. Covariates for SBP, age: F  229.98, p 
Covariates for DBP, age: F  39.34, p  4.4E-10; sex: F  28.64, p  9.78E-8;
types on both BP in vivo and gene expression in cella. (E) CHGB promoter polymo
extreme values. (Left) CHGB promoter haplotype CA in a Nigerian sample: copy nu
0.018; and BMI: F  3.07, p  0.081. Covariates for DBP, sex: F  2.589, p 
moter haplotype effects on BP in a Nigerian BP extreme sample. Covariates for SB
0.012. Covariates for DBP, sex: F  5.12, p  0.024; age: F  4.94, p  0.027aplotypes and hypertension was also found in a Nigerian (opulation selected for extreme BP values (top and bottom
5th percentiles; p 0.007 for BP status) (Online Table 3).
ere, haplotype -296C/A-261 increased SBP by 34 mm
g (p  0.002) and DBP by 22 mm Hg (p  3.52E-4)
Fig. 4E, left). The rank order of overall haplotypic variation
n blood pressure (Fig. 4E, right) was AA, ATCTCA
SBP/DBP: p  0.007/p  0.002). Whereas haplotype CA
as associated with higher BP in both black subjects and white
ubjects, haplotype AT predicted higher BP only in whites.
owever, CHGB promoter allele and haplotype frequencies
iffered substantially between black subjects and white subjects
vo and gene expression in cella. (Left) CHGB promoter haplotypes as predictors
E-49; sex: F  16.64, p  4.718E-5; and BMI: F  380.19, p  2.27E-77.
I: F  550.08, p  5.5E-107. (Right) Parallel effects of CHGB promoter haplo-
s A-296C/A-261T: haplotype effects on BP in a black (Nigeria) sample with trait
effect. Covariates for SBP, sex: F  0.684, p  0.4092; age: F  5.63, p 
age: F  2.48, p  0.116; and BMI: F  4.65, p  0.032. (Right) CHGB pro-
: F  1.375, p  0.241; age: F  11.26, p  0.001; and BMI: F  6.34, p 
MI: F  9.48, p  0.002.P in vi
3.83
and BM
rphism
mber
0.108;
P, sex
, and BOnline Table 2), perhaps contributing to different haplotype
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CHGB Transcription and Hypertension April 6, 2010:1463–75ffects on BP; for example, haplotype AT is relatively unusual
n white persons but far more common in black persons (Fig.
E, Online Table 2). The CHGB promoter haplotypes did not
learly differ in effects on BP between sexes.
ntermediate trait. ASSOCIATION OF HERITABLE BP RESPONSE
O ENVIRONMENTAL STRESS WITH CHGB PROMOTER
ARIANTS A-296C AND A-261T. In predominantly (90%)
ormotensive white twin pairs (n  163 pairs), the DBP
esponse to environmental (cold) stress was substantially
eritable (h2  32 	 8%, p  0.0003) (46). The CHGB
romoter individual genotypes A-296C (AC, p 0.0237)
nd A-261T (AT, p  0.037) predicted change DBP

DBP) in the cold stress test. Because of the modest
ample size (2n  326 chromosomes), we observed only 5
xamples of CA haplotypes and 1 AT haplotype, so analyses
ould only be performed for haplotypes AA and CT.
onsistent with basal BP in white BP extremes (Fig. 4A),
he CT haplotype decreased the stress 
DBP, while the AA
aplotype increased 
DBP (Fig. 5); thus, the rank order of
ffects of the haplotypes on BP was preserved in twins
AACT), although the effects of the more prominent
P-increasing haplotypes (CA, AT) could not be quantified
n this predominantly normotensive sample.
iscussion
verview. Patients with hypertension often exhibit in-
reased sympathetic activity (47,48), and hypertension tends
o develop in persons with sympathetic overactivity (49,50).
uppression of CHGB expression in chromaffin cells leads to
reduction in the number of catecholamine secretory
ranules, whereas ectopic expression of CHGB in nonneu-
oendocrine cells, which normally do not contain regulated
ecretory machinery, leads to granule biogenesis (6). In light
f the emerging secretory biology of CHGB, we undertook
he present study to probe how heredity shapes human
unctional responses in the sympathetic neuroeffector junc-
ion, using CHGB as a likely focal point in the pathogenesis
f essential hypertension. Recently, we reported CHGB
aplotype effects on BP across the CHGB locus, suggesting
hat the major effect was located in the 5’/promoter region
CHGB Common Promoter Variant Effects on Bloin a Eur pean Ancestry Popul tion Sample WithTable 2 CHGB Comm n Promoter Variant Efin a European Ancestry Population
Haplotype HT NT
AA 437 (0.534) 610 (0.562)
AT 67 (0.082) 19 (0.018)
CA 74 (0.091) 27 (0.025)
CT 240 (0.293) 428 (0.394)
Total n 818 1084
Global chi-square 93.9
p value 3.16E-20
This case/control study of CHGB promoter common SNPs and haploty
the program SHEsis (41). Bold values indicate significant p values (p
the indicated haplotype or genotype.
CI  confidence interval; HT  hypertensive; NT  nonmotensive.26), and the effect of CHGB on intermediate traits seems toe quantitative rather than qualitative; thus, we focused here
n promoter variation at the CHGB locus. We also noted a
ex-dependent effect of CHGB polymorphism on BP (26);
ere, we defined the effect of genetic variation on gene
xpression, and found evidence that the response of the gene
o the male-determination factor SRY was altered by 1
romoter variant (A-261T), raising a potential mechanism
or the well-known sexual dimorphism in BP.
HGB promoter common variants. Transcriptional
echanisms of action. We identified 2 common variants in
he CHGB proximal promoter: A-296C and A-261T. Here,
e established that these 2 variants occur in evolutionary
onserved regions, and can create or interrupt particular
ranscriptional control motifs. We probed these processes in
ways: by exposing the variants to the exogenous factors,
essureme BP Valueson Blood Pr sure
le With Extreme BP Values
s Ratio (95% CI) Chi-Square
Fisher’s Test
(p Value)
92 (0.743–1.070) 1.52 0.218
98 (2.933–8.180) 44.3 3.19E-11
40 (2.455–6.008) 39.5 3.64E-10
37 (0.524–0.773) 21.0 4.64E-06
th BP status in white population with BP extremes was conducted by
alues in parentheses indicate fraction of individuals in that group with
Figure 5 CHGB Promoter Common
Polymorphisms A-296C/A-261T
Chromogranin B (CHGB) promoter common polymorphisms A-296C/A-261T:
haplotype effects on change in diastolic blood pressure (
DBP) in the environ-
mental (cold) stress test in twin pairs. Diploid haplotype pair (diplotype) effects
for the 2 most common haplotypes (A¡A and C¡T) are shown. Results are
analyzed by generalized estimating equations (GEE).od PrExtrfec s
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April 6, 2010:1463–75 CHGB Transcription and Hypertensionnd by testing whether the endogenous factors recognize the
otifs.
-296C VARIANT: C-FOS MOTIF. A c-FOS motif was acti-
ated by the exogenous factor and bound by the endogenous
actor (Fig. 2). The c-FOS, a b-ZIP (leucine zipper) factor
f the immediate/early class, may heterodimerize with a
ariety of other such family members (e.g., c-JUN) to
rigger transcription, especially by activating AP-1 sites.
-261T VARIANT: YY1 AND SRY MOTIFS. This variant spanned
otifs for both YY1 and SRY (Fig. 3). Exogenous YY1
ncreased CHGB promoter expression (especially for the
-261 allele), whereas exogenous SRY decreased expres-
ion; endogenous factors YY1 and SRY each bound the
otif, preferentially for the A-261 (major) allele.
The YY1 motif is a widely expressed C2H2 zinc finger
ranscription factor whose ability to direct local histone mod-
fications within chromatin yields fundamental roles in embry-
genesis, differentiation, replication, and proliferation (51).
The SRY protein, testis-determining factor, is a high-
obility group box factor best known as an initiator of male
evelopment, in which its major transcriptional targets may
nclude SOX9 (52). Of note for hypertension, we previously
ound that promoter A-261T exerted a sex-specific effect on
opulation BP, with the effect confined to males (26). Here,
e provide a basis for that sex-specific effect, because only
ales express the SRY factor, encoded by the SRY locus
n human chromosome Yp11.31. While we focused on
he SRY motif match in the A-261T region of the CHGB
romoter (Fig. 3A), and demonstrated its binding (Fig.
A) and trans-activation (Fig. 3B) by SRY, other mem-
ers of the SOX transcription factor family, including the
RY target SOX9, may share similar consensus DNA
arget motifs (53) (i.e., SRY as WACAAW; SOX9 as
ACAAT), and hence, both constitute potential CHGB
rans-activators.
nteractions A-296C by A-261T. The likelihood of site-
y-site interactions within the CHGB promoter (Fig. 4C) is
uggested by 2 previous observations. First, the YY1 pro-
oter responds transcriptionally to c-FOS (54). Second, the
ultifunctional factor YY1 interacts noncovalently with a
ariety of other transcription factors, including members of
he b-ZIP family such as CREB (55). While we have
ocumented an interaction in cis between A-296C and
-261T in transfected CHGB promoter haplotype/
uciferase reporter plasmids (296-by-261 interaction, p 
.07E-07) (Online Table 1), we have not yet explored factor
nteractions in trans during such transfections.
HGB promoter common variants and hypertension
cross populations. The LD analysis across the CHGB
ocus indicated that the proximal CHGB promoter, includ-
ng common variants A-296C and A-261T, is maintained
ithin 1 block (Fig. 1A) in both white subjects and black
ubjects.
We enhanced power to detect genetic associations bysing population trait-extreme values (29,30). We then dound that haplotype effects upon BP in the population were
ighly significant (Fig. 4), indeed far more significant than
he effects of single SNPs alone (Table 2). Substantially
reater effects on BP by the A-296C/A-261T haplotypes
Fig. 4A) than by either SNP alone (Table 2), also speaks
oward functional SNP-by-SNP interactions in the CHGB
romoter (see transcription factor section in preceding text).
In the European ancestry population, the rank order of haplo-
ype effects on SBP or DBP was ATCAAACT (Fig.
D, left), which is the same pattern of CHGB promoter
aplotype activity in cella (Fig. 1C), lending weight to the
iewpoint that altered CHGB transcription underlies the BP
ifferences between haplotypic groups.
In an independent (African) population, allele and hap-
otype frequencies differed substantially from those in sub-
ects of European ancestry (Online Table 2). Even so, CA
aplotype copy number (0, 1, 2) influenced BP in the
igerian sample (Fig. 4E), with the same directional effect
ound in white subjects (Fig. 4B). Although haplotype AT
as found in substantial numbers in Nigerians (134 chro-
osomes), AT carriers did not display elevated BP, sug-
esting other factors (such as differences in environment or
enetic background) influencing BP in this population, or
he inclusion of other variants in the promoter LD block in
ubjects of African ancestry (Fig. 1A).
A previous large, genome-wide association case/control
tudy, the WTCCC (Wellcome Trust Case Control Consor-
ium) study, did not find association of the CHGB locus to
ypertension (56). How is our study different? First of all, the
TCCC study used the Affymetrix 500K gene chip, whose
verage marker spacing of 3  109/500  103, or 6 kbp,
id not include the CHGB promoter variants considered here;
ndeed, the closest CHGB promoter variant studied on the
ffymetrix 500K chip in the WTCCC study was rs236129,
hich is 4,729 bp upstream of the cap site. Second, the
TCCC study employed single point associations, rather
han studying haplotype or SNP-by-SNP interaction effects
which were crucial in our analyses). Third, because of rela-
ively sparse marker spacing, the HapMap approach employed
n the WTCCC study does not fully capture the full spectrum
f potentially causal allelic variation at candidate loci (57,58).
inally, the WTCCC study used unselected/unphenotyped
opulation controls (59); the high population prevalence
24%) of hypertension thus greatly diminishes the power of
he WTCCC study to detect associations with hypertension.
y contrast, our approach (31), using population trait (BP)
xtremes, offers substantially greater statistical power to detect
enetic associations; indeed, we estimate that our sample has
80% power to detect loci contributing as little as 2.5% of
P variance.
ntermediate trait. CHGB PROMOTER VARIANTS AND
ERITABLE BP RESPONSE TO ENVIRONMENTAL STRESS IN
WIN PAIRS. In longitudinal studies, the pressor response to
nvironmental (cold) stress is an effective predictor of future
evelopment of hypertension (60,61). We therefore evalu-
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CHGB Transcription and Hypertension April 6, 2010:1463–75ted whether CHGB genetic variation in the transcriptional
ontrol region might influence this risk predictor.
In a series of twin pairs, CHGB promoter common
aplotypes influenced 
DBP in the cold stress test (Fig. 5),
ith A-296/A-261 elevating and -296C/-261T diminish-
ng the pressor response, findings that are in rank order with
asal BP effects in the population (AACT) (Fig. 4A).
aplotypes associated with much higher BP in the popu-
ation extreme subjects (AT, CA) (Fig. 4A) were too
nfrequent in this predominantly normotensive twin sample
or meaningful conclusions to be drawn.
onclusions
ommon genetic variants in the CHGB proximal promoter
eem to exert a powerful, interactive effect on BP. The
HGB promoter variants A-296C and A-261T differed
ubstantially in transcriptional efficiency during luciferase
eporter activity assays (Fig. 1C), and such activity paralleled
BP and DBP in the population (Fig. 4D, right). Particular
ranscription factors (c-FOS at A-296C; YY1 and SRY at
-261T) differed in activity at the variant sites (Figs. 2 and
); such effects were captured by both cotransfection and
hIP. Differential SRY effects at A-261T suggest a mech-
nism that might ultimately contribute to the sexual dimor-
hism of BP in the population. Substantially greater effects
n BP of the variants in combination (rather than as
ndividual SNPs) suggest intrapromoter A-296C by
-261T interactions. Finally, CHGB promoter variants
redict change in BP in response to environmental stress
ven in predominantly normotensive subjects, suggesting an
arly pathway by which hypertension may ultimately be
ediated.
Thus, common genetic variation at the CHGB locus,
specially in the proximal promoter, influences CHGB
xpression, and later the early heritable responses to envi-
onmental stress, and finally resting/basal BP in the popu-
ation (Fig. 6). These results point to new molecular
Concept
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Figure 6 CHGB Genetic Variation
Chromogranin B (CHGB) genetic variation: consequences for autonomic physiol-
ogy and cardiovascular disease. The schematic presents a hypothetical frame-
work integrating the experimental results, and suggests future questions for
exploration. BP  blood pressure; SRY  sex-determining region Y; YY1 
Yin-Yang 1.trategies for probing autonomic control of the circulation,nd ultimately the susceptibility to and pathogenesis of
ardiovascular disease states such as hypertension.
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